Streptokinase versus recombinant tissue plasminogen activator for treatment of acute myocardial infarction : clinical and radionuclide follow-up

Thrombolysis with streptokinase (SK) in acute myocardial infarction has gained widespread acceptance because of its efficacy in improving survival and preserving left ventricular function. Recently, recombinant tissue plasminogen activator (rt-PA) has become the object of considerable clinical interest